Abstract
Relatively minor changes in plasma concentrations of lithium can have significant clinical ramifications. Although controlled studies of drug interactions with lithium are limited, accumulated evidence implicates drugs from several classes in the development of lithium toxicity. Consequently, clinicians treating patients with mood disorders need to take a cautious approach when combining lithium with any other medication. This is particularly pertinent in the treatment of elderly patients and those with medical comorbidities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have